BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21546720)

  • 1. Sero-prevalence of hepatitis B virus infection in Balochistan Province of Pakistan.
    Sheikh NS; Sheikh AS; Sheikh AA; Yahya S; ; Lateef M
    Saudi J Gastroenterol; 2011; 17(3):180-4. PubMed ID: 21546720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan.
    Quddus A; Luby SP; Jamal Z; Jafar T
    Int J Infect Dis; 2006 May; 10(3):242-7. PubMed ID: 16448838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan.
    Jafri W; Jafri N; Yakoob J; Islam M; Tirmizi SF; Jafar T; Akhtar S; Hamid S; Shah HA; Nizami SQ
    BMC Infect Dis; 2006 Jun; 6():101. PubMed ID: 16792819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019.
    Moonsamy S; Suchard M; Pillay P; Prabdial-Sing N
    BMC Public Health; 2022 Jan; 22(1):29. PubMed ID: 34991533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country.
    O'Connor SM; Mixson-Hayden T; Ganova-Raeva L; Djibo DA; Brown M; Xia GL; Kamili S; Jacobs M; Dong M; Thomas AG; Bulterys M; Hale B
    PLoS One; 2019; 14(10):e0222835. PubMed ID: 31574098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran.
    Khosravani A; Sarkari B; Negahban H; Sharifi A; Toori MA; Eilami O
    BMC Infect Dis; 2012 Dec; 12():378. PubMed ID: 23270391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
    Zhang L; Liu JY; Lyu JJ; Yan BY; Feng Y; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):475-479. PubMed ID: 28592088
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.
    Ashraf H; Alam NH; Rothermundt C; Brooks A; Bardhan P; Hossain L; Salam MA; Hassan MS; Beglinger C; Gyr N
    BMC Infect Dis; 2010 Jul; 10():208. PubMed ID: 20630111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimization of hepatitis B infection by a 25-year universal vaccination program.
    Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
    J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
    Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
    Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
    Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP; Nouanthong P; Nanthavong N; Souvannaso C; Vilivong K; Jutavijittum P; Samountry B; Lütteke N; Hübschen JM; Goossens S; Quet F; Buisson Y; Muller CP
    BMC Infect Dis; 2014 Aug; 14():457. PubMed ID: 25149478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment on the Effects of Hepatitis B Prevention and Control Measures in Western China: A Comparison of Three Population-based Serosurveys.
    Chen H; Liu N; Ji ZH; Pu ZS; Guo ZW; Gao J; Shao ZJ; Liu YW; Yan YP
    Biomed Environ Sci; 2020 Oct; 33(10):735-744. PubMed ID: 33228832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.